These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1144320)

  • 21. [Cardio- and hemodynamics of thyrotoxicosis patients in the late postoperative period].
    Tsarikovskaia NG; Rom-Bugoslavskaia ES; Alesina MIu; Mikhalevskaia VP
    Vrach Delo; 1982 Sep; (9):36-40. PubMed ID: 7179909
    [No Abstract]   [Full Text] [Related]  

  • 22. [Preoperative care and anesthesia in surgical treatment of thyrotoxicosis].
    Bekhtereva EI; Kuznetsov VI
    Vestn Khir Im I I Grek; 1976 Aug; 117(8):87-90. PubMed ID: 997127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The functional status of the myocardium in thyrotoxicosis].
    Maslova NP; Salim'ianova AG
    Klin Med (Mosk); 1967 Jun; 45(6):64-8. PubMed ID: 5614676
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hyperthyroidism and heart disease. Is thyrotoxic cardiomyopathy a disease entity?].
    Toft P; Bøtker HE
    Ugeskr Laeger; 1993 May; 155(18):1354-7. PubMed ID: 8497965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes of arterial pressure in patients with hyperthyroidism during therapy.
    Marcisz C; Jonderko G; Kucharz E
    Med Sci Monit; 2002 Jul; 8(7):CR502-7. PubMed ID: 12118198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [State of hemodynamics in thyrotoxicosis].
    Selivonenko VG
    Vrach Delo; 1974 Mar; (3):39-41. PubMed ID: 4468662
    [No Abstract]   [Full Text] [Related]  

  • 27. Propranolol dosage in thyrotoxicosis.
    Feely J; Forrest A; Gunn A; Hamilton W; Stevenson I; Crooks J
    J Clin Endocrinol Metab; 1980 Sep; 51(3):658-61. PubMed ID: 7410541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stress echocardiography in hyperthyroidism.
    Kahaly GJ; Wagner S; Nieswandt J; Mohr-Kahaly S; Ryan TJ
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2308-13. PubMed ID: 10404794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of imipramine on the vasomotor tone, blood supply and activity of the heart].
    Chichkanov GG
    Farmakol Toksikol; 1977; 40(6):710-4. PubMed ID: 598497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peripheral circulatory and metabolic consequences of thyrotoxicosis. 8. Venomotor tone at rest in thyrotoxic patients before and after treatment.
    Frey HM
    Scand J Clin Lab Invest; 1967; 19(4):346-50. PubMed ID: 6051929
    [No Abstract]   [Full Text] [Related]  

  • 31. Life-threatening hypercalcemia in a case of thyrotoxicosis: clinical features and management. A case report.
    Hedman I; Tisell LE
    Acta Chir Scand; 1985; 151(5):487-9. PubMed ID: 2413667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subtotal thyroidectomy for thyrotoxicosis: a reassessment, including TRH responsiveness.
    Chambers S; Brownlie BE; Turner JG; Macbeth WA
    N Z Med J; 1978 Mar; 87(607):163-6. PubMed ID: 418367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Preoperative and postoperative management of hyperthyroidism with special reference to thyroid crisis].
    Teichmann W; Köcher W; Meng W
    Zentralbl Chir; 1973 May; 98(19):703-5. PubMed ID: 4723150
    [No Abstract]   [Full Text] [Related]  

  • 34. [Subtotal thyroid resection in severe, iodine-induced hyperthyroidism].
    Hintze G; Lepsien G; Becker HD; Köbberling J
    Chirurg; 1985 Sep; 56(9):594-8. PubMed ID: 4053769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Phase analysis of heart contractions in patients with thyrotoxicosis].
    Shul'man VA
    Probl Endokrinol Gormonoter; 1966; 12(5):22-5. PubMed ID: 6002024
    [No Abstract]   [Full Text] [Related]  

  • 36. [Disorder of the thrombocytic-vascular component of hemostasis in thyrotoxicosis].
    Pavlovskiĭ DP
    Probl Endokrinol (Mosk); 1977; 23(3):32-5. PubMed ID: 887630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effect of inderal on the heart of thyrotoxicosis patients (a clinico-roentgenologic study)].
    Astapov BM; Bogoliubov VM; Matveenko EG; Konstantinov IuN; Sorokina VG
    Klin Med (Mosk); 1972 Aug; 50(8):90-5. PubMed ID: 4660362
    [No Abstract]   [Full Text] [Related]  

  • 38. [Characteristics of the clinical aspects, and hormonal and immunological status of thyrotoxicosis patients with a hereditary predisposition to endocrine diseases].
    Natarov VV; Grinchenko TS; Afanas'eva NI; Ivanov EN; Dekhtiar' DA
    Probl Endokrinol (Mosk); 1982; 28(4):9-12. PubMed ID: 7122451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Function of thyroid and hypotalamic-pituitary-thyroid axis in radioiodine treated thyrotoxic patients.
    Helds A; Lerhs E; Bolshevica J; Ozols V
    Endokrinologie; 1980 Dec; 76(3):345-50. PubMed ID: 6781880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Characteristics of erythrocyte acid and osmotic resistance in thyrotoxicosis before and after treatment].
    Tkachev VA
    Probl Endokrinol (Mosk); 1982; 28(4):12-7. PubMed ID: 6181498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.